Patents by Inventor Damodar R. Ettyreddy

Damodar R. Ettyreddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenoviral vector encoding human atonal homolog-1 (HATH1)
    Patent number: 11279951
    Abstract: The invention is directed to a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding a human atonal homolog-1 (Hath1) protein operably linked to a human glial fibrillary acidic protein (GFAP) promoter. The invention also is directed to a composition and method utilizing the adenoviral vector to generate sensory cells in the inner ear of a human.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: March 22, 2022
    Assignee: GenVec, Inc.
    Inventors: Douglas E. Brough, Damodar R. Ettyreddy
  • ADENOVIRAL VECTOR ENCODING HUMAN ATONAL HOMOLOG-1 (HATH1)
    Publication number: 20180208944
    Abstract: The invention is directed to a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding a human atonal homolog-1 (Hath1) protein operably linked to a human glial fibrillary acidic protein (GFAP) promoter. The invention also is directed to a composition and method utilizing the adenoviral vector to generate sensory cells in the inner ear of a human.
    Type: Application
    Filed: March 23, 2018
    Publication date: July 26, 2018
    Applicant: GenVec, Inc.
    Inventors: Douglas E. Brough, Damodar R. Ettyreddy
  • Adenoviral vector encoding human atonal homolog-1 (HATH1)
    Patent number: 9951351
    Abstract: The invention is directed to a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding a human atonal homolog-1 (Hath1) protein operably linked to a human glial fibrillary acidic protein (GFAP) promoter. The invention also is directed to a composition and method utilizing the adenoviral vector to generate sensory cells in the inner ear of a human.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: April 24, 2018
    Assignee: GenVec, Inc.
    Inventors: Douglas E. Brough, Damodar R. Ettyreddy
  • ADENOVIRAL VECTOR ENCODING HUMAN ATONAL HOMOLOG-1 (HATH1)
    Publication number: 20160102320
    Abstract: The invention is directed to a replication-deficient adenoviral vector comprising a nucleic acid sequence encoding a human atonal homolog-1 (Hath1) protein operably linked to a human glial fibrillary acidic protein (GFAP) promoter. The invention also is directed to a composition and method utilizing the adenoviral vector to generate sensory cells in the inner ear of a human.
    Type: Application
    Filed: October 9, 2015
    Publication date: April 14, 2016
    Applicant: GENVEC, INC.
    Inventors: Douglas E. Brough, Damodar R. Ettyreddy
  • Adenoviral vector-based malaria vaccines
    Patent number: 8765146
    Abstract: The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium nucleic acid sequences, operably linked to promoters. The invention further provides a method of inducing an immune response against malaria in a mammal comprising administering the adenoviral vectors to the mammal.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: July 1, 2014
    Assignees: GenVec, Inc., The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The United States of America, as represented by the Secretary of the Navy
    Inventors: Joseph T. Bruder, Imre Kovesdi, C. Richter King, Duncan L. McVey, Damodar R. Ettyreddy, Denise Louise Doolan, Daniel John Carucci
  • ADENOVIRAL VECTOR-BASED MALARIA VACCINES
    Publication number: 20090148477
    Abstract: The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium nucleic acid sequences, operably linked to promoters. The invention further provides a method of inducing an immune response against malaria in a mammal comprising administering the adenoviral vectors to the mammal.
    Type: Application
    Filed: August 31, 2006
    Publication date: June 11, 2009
    Applicant: GENVEC, INC.
    Inventors: Joseph T. Bruder, Imre Kovesdi, C. Richter King, Duncan L. McVey, Damodar R. Ettyreddy, Denise Louis Doolan, Daniel John Carucci, Keith Limbach